FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+41.78%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$642M
AUM Growth
+$642M
(+41%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
6.77%
Top 10 Holdings %
Top 10 Hldgs %
58.84%
Holding
55
New
3
Increased
31
Reduced
11
Closed
–
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$18.8M |
| 2 |
Omnicell
OMCL
|
$17.2M |
| 3 |
Heron Therapeutics
HRTX
|
$14.1M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$12M |
| 5 |
SHPG
Shire pic
SHPG
|
$8.4M |
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$62.3M |
| 2 |
Xencor
XNCR
|
$5.03M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$4.03M |
| 4 |
Globus Medical
GMED
|
$3.77M |
| 5 |
HealthStream
HSTM
|
$3.55M |
Sector Composition
| 1 | Healthcare | 84.94% |
| 2 | Communication Services | 3.88% |
| 3 | Energy | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.91M | 0.92% |
62,750
+30,900
| +97% | +$2.91M |
|
27
QuidelOrtho
QDEL
$1.95B
| $5.37M | 0.84% |
80,755
+4,687
| +6% | +$312K |
|
|
28
Globus Medical
GMED
$8.27B
| $5.28M | 0.82% |
104,615
-74,649
| -42% | -$3.77M |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $5.24M | 0.82% |
33,360
+7,944
| +31% | +$1.25M |
|
|
LHCG
30
DELISTED
LHC Group LLC
LHCG
| $4.65M | 0.72% |
54,360
-17,639
| -24% | -$1.51M |
|
|
NXTM
31
DELISTED
NxStage Medical Inc.
NXTM
| $4.25M | 0.66% |
152,448
-40,891
| -21% | -$1.14M |
|
32
Vertex Pharmaceuticals
VRTX
$100B
| $4.25M | 0.66% |
24,974
+1,545
| +7% | +$263K |
|
|
TLGT
33
DELISTED
Teligent, Inc
TLGT
| $3.98M | 0.62% |
1,151,032
+50,209
| +5% | +$174K |
|
34
OrthoPediatrics
KIDS
$536M
| $3.31M | 0.51% |
124,108
+7,923
| +7% | +$211K |
|
|
35
HealthStream
HSTM
$832M
| $2.5M | 0.39% |
91,635
-130,033
| -59% | -$3.55M |
|
|
STRM
36
DELISTED
Streamline Health Solutions
STRM
| $2.43M | 0.38% |
1,724,165
-173,516
| -9% | -$245K |
|
37
iShares Biotechnology ETF
IBB
$5.6B
| $2.34M | 0.36% |
21,291
| – | – |
|
|
XLVS
38
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| $2.22M | 0.35% |
17,285
| – | – |
|
39
Sangamo Therapeutics
SGMO
$157M
| $2.21M | 0.34% |
+155,348
| New | +$2.21M |
|
40
LeMaitre Vascular
LMAT
$2.16B
| $1.67M | 0.26% |
49,996
+3,086
| +7% | +$103K |
|
41
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $1.52M | 0.24% |
18,241
| – | – |
|
42
iShares US Medical Devices ETF
IHI
$4.33B
| $1.52M | 0.24% |
7,580
| – | – |
|
43
IRIDEX
IRIX
$22.8M
| $1.38M | 0.22% |
198,581
-189,106
| -49% | -$1.32M |
|
44
Alkermes
ALKS
$4.78B
| $1.33M | 0.21% |
32,271
+2,060
| +7% | +$84.8K |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $1.17M | 0.18% |
14,742
+890
| +6% | +$70.7K |
|
|
ENZ
46
DELISTED
Enzo Biochem, Inc.
ENZ
| $984K | 0.15% |
189,600
-61,402
| -24% | -$319K |
|
47
AbbVie
ABBV
$372B
| $385K | 0.06% |
4,159
| – | – |
|
|
DYNT
48
DELISTED
Dynatronics Corp
DYNT
| $313K | 0.05% |
108,885
+1,900
| +2% | +$5.46K |
|
49
Pfizer
PFE
$141B
| $310K | 0.05% |
8,558
| – | – |
|
50
Novartis
NVS
$245B
| $270K | 0.04% |
3,572
| – | – |
|